国际起始队列中抗核抗体阴性的系统性红斑狼疮
在国际起始队列的1137例新诊断系统性红斑狼疮患者中,采用HEp-2000基质间接免疫荧光检测,92.3%为抗核抗体阳性,6.2%为抗细胞抗体阴性,1.5%为孤立性细胞有丝分裂型荧光。抗细胞抗体阴性组在临床、人口学和血清学特征上与阳性组无差异;高龄、白人种族/族裔、入组时或之前接受高剂量糖皮质激素者更可能为抗细胞抗体阴性。
要点
- 新诊断SLE中6.2%为抗细胞抗体阴性,1.5%为孤立性细胞有丝分裂型荧光
- 孤立性细胞有丝分裂型荧光组与ANA阳性或抗细胞抗体阴性组在临床、人口学及血清学特征上无差异
- 高龄、白人种族/族裔、高剂量糖皮质激素与抗细胞抗体阴性相关,免疫抑制剂及抗SSA/Ro 60或抗U1 RNP抗体与阴性可能性降低相关
核心结论
- 新诊断系统性红斑狼疮中6.2%的患者为抗细胞抗体阴性,1.5%有孤立性细胞有丝分裂型荧光。
- 随着新兴命名指南推荐非核型荧光也应报告为抗核抗体阳性,抗细胞抗体阴性系统性红斑狼疮的患病率可能下降。
研究设计与样本
- 研究采用系统性红斑狼疮国际协作组(SLICC)起始队列,用基线血清在HEp-2000基质上以间接免疫荧光检测抗细胞抗体。
- 共纳入1137例患者,分为抗核抗体阳性(核型或混合核型/细胞有丝分裂型荧光)、抗细胞抗体阴性(无任何细胞内荧光)和孤立性细胞有丝分裂型荧光三个血清学亚组。
- 采用多变量分析评估抗细胞抗体阴性相对于抗核抗体阳性或孤立性细胞有丝分裂型荧光阳性的比值比。
主要发现
- 1137例患者中,1049例(92.3%)为抗核抗体阳性,71例(6.2%)为抗细胞抗体阴性,17例(1.5%)为孤立性细胞有丝分裂型荧光。
- 孤立性细胞有丝分裂型荧光阳性组与抗核抗体阳性组或抗细胞抗体阴性组在临床、人口学或血清学特征上无差异。
- 高龄(OR 1.02 [95%CI 1.00, 1.04])、白人种族/族裔(OR 3.53 [95%CI 1.77, 7.03])、入组时或之前接受高剂量糖皮质激素(OR 2.39 [95%CI 1.39, 4.12])者更可能为抗细胞抗体阴性。
- 使用免疫抑制剂(OR 0.35 [95%CI 0.19, 0.64])、抗SSA/Ro 60抗体(OR 0.41 [95%CI 0.23, 0.74])或抗U1 RNP抗体(OR 0.43 [95%CI 0.20, 0.93])者更不可能为抗细胞抗体阴性。
关键数值与推荐
- 抗核抗体阳性定义为核型或混合核型/细胞有丝分裂型荧光染色阳性,共1049/1137例(92.3%)。
- 抗细胞抗体阴性定义为无任何细胞内荧光染色,共71/1137例(6.2%)。
- 孤立性细胞有丝分裂型荧光定义为仅有细胞有丝分裂型荧光染色,共17/1137例(1.5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The spectrum of antinuclear antibodies (ANAs) is changing to include both nuclear staining as well as cytoplasmic and mitotic cell patterns (CMPs) and accordingly a change is occurring in terminology to anticellular antibodies. This study examined the prevalence of indirect immunofluorescence (IIF) anticellular antibody staining using the Systemic Lupus International Collaborating Clinics inception cohort. METHODS: Anticellular antibodies were detected by IIF on HEp-2000 substrate using the baseline serum. Three serologic subsets were examined: ANA positive (presence of either nuclear or mixed nuclear/CMP staining), anticellular antibody negative (absence of any intracellular staining), and isolated CMP staining. The odds of being anticellular antibody negative versus ANA or isolated CMP positive was assessed by multivariable analysis. RESULTS: A total of 1,137 patients were included; 1,049 (92.3%) were ANA positive, 71 (6.2%) were anticellular antibody negative, and 17 (1.5%) had an isolated CMP. The isolated CMP-positive group did not differ from the ANA-positive or anticellular antibody-negative groups in clinical, demographic, or serologic features. Patients who were older (odds ratio [OR] 1.02 [95% confidence interval (95% CI) 1.00, 1.04]), of white race/ethnicity (OR 3.53 [95% CI 1.77, 7.03]), or receiving high-dose glucocorticoids at or prior to enrollment (OR 2.39 [95% CI 1.39, 4.12]) were more likely to be anticellular antibody negative. Patients on immunosuppressants (OR 0.35 [95% CI 0.19, 0.64]) or with anti-SSA/Ro 60 (OR 0.41 [95% CI 0.23, 0.74]) or anti-U1 RNP (OR 0.43 [95% CI 0.20, 0.93]) were less likely to be anticellular antibody negative. CONCLUSION: In newly diagnosed systemic lupus erythematosus, 6.2% of patients were anticellular antibody negative, and 1.5% had an isolated CMP. The prevalence of anticellular antibody-negative systemic lupus erythematosus will likely decrease as emerging nomenclature guidelines recommend that non-nuclear patterns should also be reported as a positive ANA.
引用
- Choi MY, Clarke AE, St Pierre Y, et al. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care Res (Hoboken). 2019. PMID: 30044551. doi:10.1002/acr.23712
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。